Synlett 2002(8): 1233-1236
DOI: 10.1055/s-2002-32982
LETTER
© Georg Thieme Verlag Stuttgart · New York

One Step Synthesis of Dihydropyridin-2-imines: Inhibitors of Inducible Nitric Oxide Synthase

Yasufumi Kawanaka*b, Kaoru Kobayashia, Shinya Kusudaa, Tadashi Tatsumia, Masanori Murotaa, Toshihiko Nishiyamaa, Katsuya Hisaichia, Atsuko Fujiia, Keisuke Hiraia, Masao Nakaa, Masaharu Komenoa, Hisao Nakaia, Masaaki Todaa
a Minase Research Institute, Ono Pharmaceutical Co., Ltd., Shimamoto, Mishima, Osaka 618-8585, Japan
b Fukui Research Institute, Ono Pharmaceutical Co., Ltd., Technoport, Yamagishi, Mikuni, Sakai, Fukui 913-8538, Japan
Fax: +81(776)828420; e-Mail: kawanaka@ono.co.jp;
Further Information

Publication History

Received 15 May 2002
Publication Date:
25 July 2002 (online)

Abstract

An exclusive one step synthesis of dihydropyridin-2-imines 2 or 3, both of which are potent inhibitors of inducible nitric oxide (iNOS), from the common starting material 2-aminopyridine 1 was successfully carried out using the Birch reduction followed by the appropriate work-up procedure. The application of this reduction to other substituted 2-aminopyridines 4-8 and 2-hydroxypyridine 9 are reported. The reaction mechanism is also discussed.

    References

  • 1 Moncada S. Palmer RMJ. Higgs EA. Pharmacol. Rev.  1991,  43:  109 
  • 2 Nathan CF. FASEB  1992,  6:  3051 
  • 3 Stuehr DJ. Griffith OW. Adv. Enzymol. Rev. Mol. Biol.  1992,  65:  287 
  • 4 Marletta MA. J. Biol. Chem.  1993,  268:  12231 
  • 5 Förstermann U. Closs EI. Pollock JS. Nakane M. Schwarz P. Gath I. Kleinert H. Hypertension  1994,  23:  1121 
  • 6 Moncada S. Higgs A. New Engl. J. Med.  1993,  329:  2002 
  • 7 Kerwin JF. Heller M. Med. Res. Rev.  1994,  14:  23 
  • 8 Kerwin JF. Lancaster JR. Feldman PL. J. Med. Chem.  1995,  38:  4343 
  • 10 Danishefsky S. Nagel A. J. Chem. Soc., Chem. Commun.  1972,  373 
  • 11 Birch AJ. Lehman PG. J. Chem. Soc., Perkin Trans. 1  1973,  2754 
  • 12 Birch AJ. Karakhanov EA. J. Chem. Soc., Chem. Commun.  1975,  480 
  • 13 Preparation of 2 from 1: To a stirred solution of 2-amino-4-methylpyridine 1 (2 g, 18.5 mmol) in THF (6.2 mL) and EtOH (2.2 mL) liquid NH3 (60 mL) was added at -78 °C. Small pieces of lithium metal (320 mg, 46.2 mmol) were added to the reaction mixture and the solution stirred for an additional 1.5 h at -78 °C before quenched with solid NH4Cl (75 g). The reaction mixture was slowly warmed up to r.t. removing the ammonia with a stream of nitrogen and then treated with aq NH4Cl. The reaction mixture was extracted with CHCl3 (100 mL × 4). The combined organic layers were dried (Na2SO4) and evaporated to afford 2 as a pale yellow oil, which was converted to its hydrochloride with 4 M HCl/EtOAc-EtOH at 0 °C and further purified by column chromatography on a silica gel using CHCl3/MeOH = 5:1 as the eluent (pale yellow solid: 1.8 g, 66%): TLC Rf = 0.38 (CHCl3/MeOH/HOAc = 10:1:1). IR (KBr): 3327, 3138, 1692, 1639, 1614, 1528, 1443, 1383, 1370, 1344, 1178, 1052, 987, 849, 785, 677 cm-1. 1H NMR (200 MHz, CDCl3): δ = 9.30-9.15 (br, 1 H), 9.15-8.95 (br, 1 H), 8.65-8.50 (br, 1 H), 6.24 (s, 1 H), 3.50 (t, J = 7.5 Hz, 2 H), 2.43 (t, J = 7.6 Hz, 2 H), 2.05 (s, 3 H). MS (APCI, Pos.): m/z = 111 (M + H)+
9

Kawanaka, Y.; Kobayashi, K.; Kusuda, S.; Tatsumi, T.; Murota, M.; Nishiyama, T.; Hisaichi, K.; Fujii, A.; Hirai, K.; Naka, M.; Komeno, M.; Nakai, H.; Toda, M. Bioorg. Med. Chem. Lett. under submission.

14

Preparation of 3 from 1: To a stirred solution of 2-amino-4-methylpyridine 1 (1.0 g, 9.2 mmol) in THF (3.1 mL) and EtOH (1.1 mL) liquid NH3 (30 mL) was added at -78 °C. Small pieces of lithium metal (210 mg, 30.3 mmol) were then added to the reaction mixture and the solution stirred for an additional 1.5 h at -78 °C before quenched with a small amount of water (4 mL). The reaction mixture was slowly warmed up to r.t. removing the ammonia with a stream of nitrogen and then treated with additional water (20 mL). The reaction mixture was extracted with CHCl3 (20 mL × 3). The combined organic layers were dried (Na2SO4) and eva-porated to afford 3 as a pale yellow oil, which was converted to its hydrochloride with 4 M HCl/EtOAc-EtOH at 0 °C and further purified by column chromatography on a silica gel using CHCl3/MeOH = 5/1 as the eluent (pale yellow solid: 860 mg, 64%): TLC Rf = 0.38 (CHCl3/MeOH/HOAc = 10/1/1). IR (KBr): 3292, 3137, 2979, 2944, 2878, 1718, 1682, 1544, 1417, 1356, 1305, 1154, 1016, 946, 866, 812, 600
cm-1. 1H NMR (200 MHz, CDCl3): δ = 10.15-9.95 (br, 1 H), 9.05-8.95 (br, 1 H), 8.90-8.65 (br, 1 H), 5.55 (br, 1 H), 4.05-3.90 (m, 2 H), 3.22 (t, J = 5.1 Hz, 2 H), 1.80 (s, 3 H). MS (APCI, Pos.): m/z = 111 (M + H)+.